Absolute Antibody Drug Discovery & Development Products & Reviews

Absolute Antibody offers a large catalog of 75+ tumor marker antigen antibodies, including anti-TAA (tumor associated antigens) and anti-TSA (tumor specific antigens). Absolute Antibody recombinant antibody technology and antibody engineering has been used to generate different engineered formats of these antibodies for all your experimental needs.

Absolute Antibody recombinant engineered antibodies empower virology researchers by providing tools that meet the demands of today’s scientific inquiries.

Absolute Antibody carries a variety of recombinant antibodies to aid in neuroscience research, with targets implicated in neurotransmission, neurodevelopment, neuropathology, substance abuse, and more.

Absolute Antibody provides a range of research-grade biosimilar antibodies, including Trastuzumab, Gemtuzumab, Rituximab, Infliximab, Daclizumab, Basiliximab, Cetuximab, and Eculizumab. Each biosimilar is available in the original human format and can also be customized with a mouse, rabbit, rhesus monkey, or cynomolgus monkey constant domain.

Absolute Antibody has harnessed recombinant antibody technology to develop a comprehensive collection of engineered recombinant antibodies.

Absolute Antibody specializes in offering DNA/RNA Research Antibodies, providing a robust selection of recombinant engineered antibodies that target intricate nucleotide structures. Its tailored antibodies are designed to support the growing demands of DNA/RNA research, facilitating understanding of the intricate mechanisms governing genetic and cellular processes.

Antibody expression platforms from Absolute Antibody rapidly produce high-quality, animal-free recombinant antibodies at milligram-to-gram scale in HEK or CHO cells.